221 related articles for article (PubMed ID: 24167110)
1. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control.
Thieme D; Rautenberg C; Grosse J; Schoenfelder M
Drug Test Anal; 2013; 5(11-12):819-25. PubMed ID: 24167110
[TBL] [Abstract][Full Text] [Related]
2. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
[TBL] [Abstract][Full Text] [Related]
4. Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine.
Casilli A; Piper T; de Oliveira FA; Padilha MC; Pereira HM; Thevis M; de Aquino Neto FR
Drug Test Anal; 2016 Nov; 8(11-12):1204-1211. PubMed ID: 27739243
[TBL] [Abstract][Full Text] [Related]
5. Carbon isotope ratio mass spectrometry for detection of endogenous steroid use: a testing strategy.
Ahrens BD; Butch AW
Drug Test Anal; 2013 Jul; 5(7):534-40. PubMed ID: 23303562
[TBL] [Abstract][Full Text] [Related]
6. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
7. Investigations on changes in ¹³C/¹²C ratios of endogenous urinary steroids after pregnenolone administration.
Piper T; Schlug C; Mareck U; Schänzer W
Drug Test Anal; 2011 May; 3(5):283-90. PubMed ID: 21538944
[TBL] [Abstract][Full Text] [Related]
8. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control.
Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P
Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892
[TBL] [Abstract][Full Text] [Related]
9. Sensitive detection of testosterone and testosterone prohormone administrations based on urinary concentrations and carbon isotope ratios of androsterone and etiocholanolone.
Piper T; Haenelt N; Fusshöller G; Geyer H; Thevis M
Drug Test Anal; 2021 Nov; 13(11-12):1835-1851. PubMed ID: 34648228
[TBL] [Abstract][Full Text] [Related]
10. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control.
Brailsford AD; Gavrilović I; Ansell RJ; Cowan DA; Kicman AT
Drug Test Anal; 2012 Dec; 4(12):962-9. PubMed ID: 22761127
[TBL] [Abstract][Full Text] [Related]
12. 13C/12C ratios of endogenous urinary steroids investigated for doping control purposes.
Piper T; Flenker U; Mareck U; Schänzer W
Drug Test Anal; 2009 Feb; 1(2):65-72. PubMed ID: 20355178
[TBL] [Abstract][Full Text] [Related]
13. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
[TBL] [Abstract][Full Text] [Related]
14. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Badoud F; Boccard J; Schweizer C; Pralong F; Saugy M; Baume N
J Steroid Biochem Mol Biol; 2013 Nov; 138():222-35. PubMed ID: 23796409
[TBL] [Abstract][Full Text] [Related]
15. Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva.
Schönfelder M; Hofmann H; Schulz T; Engl T; Kemper D; Mayr B; Rautenberg C; Oberhoffer R; Thieme D
Drug Test Anal; 2016 Nov; 8(11-12):1186-1196. PubMed ID: 27723957
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and isotopic signature of short-term DHEA administration in women: Comparison with findings in men.
Buisson C; Frelat C; Privat K; Martinat N; Audran M; Collomp K
Drug Test Anal; 2018 Nov; 10(11-12):1744-1754. PubMed ID: 30315670
[TBL] [Abstract][Full Text] [Related]
18. Carbon isotope ratio determination and investigation of seized testosterone preparations.
Forsdahl G; Östreicher C; Koller M; Gmeiner G
Drug Test Anal; 2011; 3(11-12):814-9. PubMed ID: 22102298
[TBL] [Abstract][Full Text] [Related]
19. Certification of steroid carbon isotope ratios in a freeze-dried human urine reference material.
Munton E; Liu FH; John Murby E; Brynn Hibbert D
Drug Test Anal; 2012 Dec; 4(12):928-33. PubMed ID: 22544546
[TBL] [Abstract][Full Text] [Related]
20. Testosterone and doping control.
Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
